Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

824.06
-5.7000-0.69%
Pre-market: 811.00-13.0600-1.58%08:35 EDT
Volume:3.80M
Turnover:3.13B
Market Cap:781.35B
PE:70.37
High:832.35
Open:827.20
Low:811.64
Close:829.76
Loading ...

LLY's Q4 Earnings Beat, Mounjaro, Zepbound Sales Fall Shy of Estimates

Zacks
·
06 Feb

Why Eli Lilly Stock Popped on Thursday

Motley Fool
·
06 Feb

Pre-Markets Higher on Easy Jobless Claims, Q4 Earnings

Zacks
·
06 Feb

Lilly Exec Says U.S. Prescriptions of Alzheimer's Drug Kisunla Steadily Increasing Since Launch

THOMSON REUTERS
·
06 Feb

Lilly Exec Says in Q4 Zepbound Became the Market Leader in the Anti-Obesity Market as Measured by New Prescriptions

THOMSON REUTERS
·
06 Feb

Lilly Exec Says Uptake of Single-Use Zepbound Vials Increased in Q4 Through Direct to Consumer Website Sales - Conf Call

THOMSON REUTERS
·
06 Feb

Lilly Exec Says U.S. Zepbound Performance Is Going Very Well

THOMSON REUTERS
·
06 Feb

Lilly Exec Says Co Plans to Start Several Trials Assessing Incretins in Areas Such as Brain Health, Substance Use Disorders, Pain, Others

THOMSON REUTERS
·
06 Feb

Eli Lilly's Disappointing Quarter Was Already Baked In -- Barrons.com

Dow Jones
·
06 Feb

Eli Lilly Stock Jumps 2.8% While AstraZeneca up 4% After Earnings

Tiger Newspress
·
06 Feb

Lilly's Weight-Loss Drug Bonanza Continues -- Market Talk

Dow Jones
·
06 Feb

Eli Lilly and Co reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Thursday

MT Newswires Live
·
06 Feb

Investor Sentiment Muted Amid Earnings Deluge, Stifling US Equity Futures Pre-Bell

MT Newswires Live
·
06 Feb

the American Diabetes Association and Lilly Collaborate on New Resources for Obesity Care

THOMSON REUTERS
·
06 Feb

Eli Lilly reports mixed earnings, increases 2025 guidance

Yahoo Finance
·
06 Feb